Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/03/064721
CTRI/2024/03/064721
Not yet recruiting
Phase 3

Randomized controlled clinical trial to evaluate an add on effect of Tagar Vati in the management of Essential Hypertension. - NI

Dr Vidya Rajendra Jatti0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I10- Essential (primary) hypertension

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Dr Vidya Rajendra Jatti
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Vidya Rajendra Jatti

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients having Stage I hypertension, isolated systolic and isolated diastolic hypertension.
  • •2\. Patients who is known case of Hypertension but not suffering from more than 10 years. Also known case of hypertension with or without antihypertensive.
  • •3\. Shirashool, Bhrama, Klama, Hridspandana, Anidra, Swedadhikya ,Shwaskashtata patient having these symptoms of Hypertension will be included in the clinical study .
  • •4\. Patients in between 20 to 60 years of age.
  • •5\. Patients having serum creatinine level less than 1\.5 mg/dl.
  • •6\. Patients with raised blood pressure with Beta blocker.

Exclusion Criteria

  • •1\. Patients having Stage II, stage III and above known case of hypertension will be excluded.
  • •2\. Pregnant women and lactating mothers.
  • •3\. Patient suffering from any other serious systemic illness like cerebrovascular diseases, Acute Haemorrhagic conditions, Acute septic shock etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical trial of APMV2020 in Covid 19 subjects
CTRI/2021/06/034254Meyer Organics Pvt Ltd320
Not yet recruiting
Phase 2
To study the effect of ayurvedic formulation in sciaticaHealth Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere
CTRI/2024/07/071306Dr Aishwarya ghatage
Not yet recruiting
Not Applicable
Randomized controlled clinical study to evaluate a web application (App) to manage and optimize medicatioT78K71K74I12.0I13N18N14I10E78I25E11I50E14Y57.9Adverse effects, not elsewhere classifiedToxic liver diseaseFibrosis and cirrhosis of liverHypertensive renal disease with renal failureHypertensive heart and renal diseaseChronic kidney diseaseDrug- and heavy-metal-induced tubulo-interstitial and tubular conditionsEssential (primary) hypertensionDisorders of lipoprotein metabolism and other lipidaemiasChronic ischaemic heart diseaseType 2 diabetes mellitusHeart failureUnspecified diabetes mellitusDrug or medicament, unspecified
DRKS00027175Charité Campus Virchow-Klinikum128
Not yet recruiting
Phase 2
To study the effect of ayurvedic formulation in hyper lipidimaHealth Condition 1: E784- Other hyperlipidemia
CTRI/2024/08/072604Dr Shraddha Shankar Wavare
Completed
Not Applicable
Randomized controlled clinical trial evaluating the soft tissue attachment and morphology under different microbiological conditions comparing Zirconia and Titanium dental implants.K08.1Loss of teeth due to accident, extraction or local periodontal disease
DRKS00008591Zentrum für Zahnmedizin, Klinik für Rekonstruktive Zahnmedizin, Universität Zürich42